Effects of natalizumab on work ability in patients with relapsing-remitting multiple sclerosis: results from the WANT observational study

被引：0
|
作者：
Capra, R. [1 ]
De Rossi, N. [1 ]
Masera, S. [2 ]
Zipoli, V. [2 ]
Morra, V. Brescia [3 ]
Mirabella, M. [4 ]
Patti, F. [5 ]
机构：
[1] Multiple Sclerosis Ctr, Spedali Civili Brescia, Montichiari, Italy
[2] Biogen, Cambridge, MA USA
[3] Univ Federico II, Dept Neurosci & Reprod & Odontostomatol Sci, Naples, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Multiple Sclerosis Ctr, Rome, Italy
[5] Univ Catania, Multiple Sclerosis Ctr, Neurosci Sect, DANA Dept, Catania, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P558
引用
收藏
页码：264 / 265
页数：2
相关论文
共 50 条
  • [1] Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
    Ruggero Capra
    Vincenzo Brescia Morra
    Massimiliano Mirabella
    Claudio Gasperini
    Cinzia Scandellari
    Rocco Totaro
    Nicola De Rossi
    Silvia Masera
    Valentina Zipoli
    Francesco Patti
    [J]. Neurological Sciences, 2021, 42 : 2837 - 2845
  • [2] Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
    Capra, Ruggero
    Morra, Vincenzo Brescia
    Mirabella, Massimiliano
    Gasperini, Claudio
    Scandellari, Cinzia
    Totaro, Rocco
    De Rossi, Nicola
    Masera, Silvia
    Zipoli, Valentina
    Patti, Francesco
    [J]. NEUROLOGICAL SCIENCES, 2021, 42 (07) : 2837 - 2845
  • [3] Natalizumab Discontinuation: Observational Study of University of Colorado Patients with Relapsing-Remitting Multiple Sclerosis
    Nnunukwe, Ngozi
    Schreiner, Teri
    [J]. NEUROLOGY, 2012, 78
  • [4] Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet"
    Popova, E. V.
    Brylev, L. V.
    Davydovskaya, M. V.
    [J]. ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 79 - +
  • [5] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [6] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [7] Switching from natalizumab to ocrelizumab in patients with relapsing-remitting multiple sclerosis
    Van Lierop, Z.
    Toorop, A.
    Willemse, E.
    Strijbis, E.
    Kalkers, N.
    Moraal, B.
    Barkhof, F.
    Teunissen, C.
    Killestein, J.
    Van Kempen, Z.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 310 - 311
  • [8] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S303 - S303
  • [9] Natalizumab in spinal relapsing-remitting multiple sclerosis
    Zecca, C.
    Kamm, C.
    Riccitelli, G. C.
    Heldner, M.
    Caporro, M.
    Gobbi, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
  • [10] Efficacy and safety of natalizumab in relapsing-remitting multiple sclerosis: an Italian multicentre observational study
    Bucello, S.
    Sangalli, F.
    Moiola, L.
    Annovazzi, P.
    Rizzo, A.
    Radaelli, M.
    Ghezzi, A.
    Grimaldi, L.
    Martinelli, V.
    Comi, G.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S129 - S130
12345